对于降低骨关节炎风险而言,他类药物治疗的潜在益处:孟德尔的随机化研究
Lili Zhang1, Laijian Sui2, Jing Li1
1The Affiliated Hospital of Qingdao University, Qingdao, China.
Arthritis care & research
|April 4, 2024
概括
这项研究发现,使用他类药物可以预防骨关节炎 (OA) 风险. 特定的他类药物,如阿托瓦斯塔丁和西姆瓦斯塔丁,对膝关节和部OA具有保护作用.
科学领域:
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 骨关节炎 (OA) 是一种常见的退行性关节疾病,具有重大公共卫生影响.
- 类药物是广泛处方的降胆固醇药物,但它们对OA风险的影响尚未完全理解.
研究的目的:
- 调查使用他类药物和患骨关节炎的风险之间的潜在因果关系.
- 为了区分特定他类药物对OA风险的影响.
主要方法:
- 采用孟德尔随机化 (MR) 分析,使用来自英国生物银行,FinnGen和arcOGEN的大规模遗传数据.
- 使用两个样本的MR与反变量加权 (IVW) 作为主要方法,并补充了MR-Egger,加权中位数和加权模式.
- 进行敏感性分析以确保发现的稳定性,并通过SMR分析探索HMGCR表达的作用.
主要成果:
- MR 分析表明,他类药物使用与骨关节炎风险之间存在显著的保护性关联.
- 阿托瓦斯塔丁和罗斯瓦斯塔丁对关节骨质炎有因果作用,而阿托瓦斯塔丁与膝关节骨质炎风险降低有关.
- 西姆瓦斯塔丁在膝盖和部骨关节炎上都表现出保护作用,这表明它具有类效应.
结论:
- 达丁类药物治疗似乎是预防骨关节炎发展的保护因素.
- 这些发现表明,他类药物对OA的保护机制可能不仅仅与其降脂作用有关.
- 需要进一步的研究来阐明所涉及的精确生物途径.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
659
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
659
01:11Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126